# TUXARIN ER
> **NDA206323** · New Drug Application · Sponsor: MAINPOINTE · Approved 2015-06-22
## Drug
- **FDA Application Number:** NDA206323
- **Application type:** New Drug Application
- **Brand name:** TUXARIN ER
- **Generic name:** CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE
- **Active ingredients:** CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MAINPOINTE
- **Manufacturer:** Mainpointe Pharmaceuticals
- **First approval:** 2015-06-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206323)
---
*AI Analytics · CC0 1.0*